Skip to main content
. 2021 Sep 17;61(12):1521–1533. doi: 10.1002/jcph.1949

Figure 3.

Figure 3

Forest plot of the pooled analysis evaluating the effect of NSAIDs on risk of SARS‐CoV‐2 infection and risk of severe SARS‐CoV‐2 infection, only with cohort studies. A sensitivity analysis was not performed for the mortality outcome since all the studies that assessed mortality were cohorts. NSAIDs, nonsteroidal anti‐inflammatory drugs; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2.